SeaLife Pharma Overview

  • Founded
  • 2008
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

SeaLife Pharma General Information


Developer of bio-active compounds and antibiotics intended to derive from the chemical diversity of marine fungi. The company's compounds and antibiotics focus on the discovery and development of bioactive substances of marine origin to treat infections caused by multi-drug resistant pathogens, enabling medical companies to prepare natural drugs with no side effects.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Primary Office
  • Technopark 1/Obj.C/EG
  • Tulln, 3430
  • Austria
+43 0664 0000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SeaLife Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Jan-2019 00.000 Completed Out of Business
2. Grant 01-May-2015 00.00 00.000 Completed Generating Revenue
1. Early Stage VC 04-Apr-2011 $2.81M $2.81M Completed Startup
To view SeaLife Pharma’s complete valuation and funding history, request access »